Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 061866
Company: GLAXOSMITHKLINE
Company: GLAXOSMITHKLINE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ANSPOR | CEPHRADINE | 125MG/5ML | FOR SUSPENSION;ORAL | Discontinued | None | No | No |
ANSPOR | CEPHRADINE | 250MG/5ML | FOR SUSPENSION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/15/1974 | ORIG-1 | Approval |
Label is not available on this site. |